Literature DB >> 22752476

Height assessments in children with neurofibromatosis type 1.

Elizabeth A Soucy1, Dorothy van Oppen, Nicole L Nejedly, Feng Gao, David H Gutmann, Abby S Hollander.   

Abstract

Previous studies have suggested that children with neurofibromatosis type 1 (NF1) are shorter than their unaffected counterparts. Unfortunately, these reports did not consider other contributing factors that might also influence short stature. The purpose of the current study was to characterize the genetic influence of NF1 on the growth of children. Height data were measured and recorded for 170 patients, whereas parental measurements were obtained for 61 patients to calculate sex-corrected mid-parental target heights. Children with NF1 had population mean height and mid-parental height z scores statistically different from the general population. Importantly, these differences were pronounced when neither parent had NF1 but were not significant when one of the parents had NF1. Moreover, height z scores for children with NF1 were also statistically different than their unaffected siblings. Collectively, these data establish a clear effect of a germline NF1 gene mutation on stature in children with NF1.

Entities:  

Mesh:

Year:  2012        PMID: 22752476      PMCID: PMC3947790          DOI: 10.1177/0883073812446310

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  23 in total

1.  A genome-wide scan for loci affecting normal adult height in the Framingham Heart Study.

Authors:  Nandita Mukhopadhyay; David N Finegold; Martin G Larson; L Adrienne Cupples; Richard H Myers; Daniel E Weeks
Journal:  Hum Hered       Date:  2003       Impact factor: 0.444

2.  National estimates of the timing of sexual maturation and racial differences among US children.

Authors:  Shumei S Sun; Christine M Schubert; William Cameron Chumlea; Alex F Roche; Howard E Kulin; Peter A Lee; John H Himes; Alan S Ryan
Journal:  Pediatrics       Date:  2002-11       Impact factor: 7.124

3.  Growth in North American white children with neurofibromatosis 1 (NF1).

Authors:  J Szudek; P Birch; J M Friedman
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

4.  Standards for children's height at ages 2-9 years allowing for heights of parents.

Authors:  J M Tanner; H Goldstein; R H Whitehouse
Journal:  Arch Dis Child       Date:  1970-12       Impact factor: 3.791

5.  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

Authors: 
Journal:  Arch Neurol       Date:  1988-05

6.  Normal ages of pubertal events among American males and females.

Authors:  P A Lee
Journal:  J Adolesc Health Care       Date:  1980-09

7.  Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls.

Authors:  R Eldridge; M B Denckla; E Bien; S Myers; M I Kaiser-Kupfer; A Pikus; S L Schlesinger; D M Parry; J M Dambrosia; M A Zasloff
Journal:  Am J Dis Child       Date:  1989-07

8.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

9.  Growth hormone deficiency in children with neurofibromatosis type 1 without suprasellar lesions.

Authors:  R Vassilopoulou-Sellin; M J Klein; J K Slopis
Journal:  Pediatr Neurol       Date:  2000-05       Impact factor: 3.372

10.  Precocious puberty in children with neurofibromatosis type 1.

Authors:  R Habiby; B Silverman; R Listernick; J Charrow
Journal:  J Pediatr       Date:  1995-03       Impact factor: 4.406

View more
  10 in total

1.  Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients.

Authors:  Sara Lomelino Pinheiro; Joana Maciel; Daniela Cavaco; Ana Abrantes Figueiredo; Inês Lemos Damásio; Sara Donato; João Passos; Joana Simões-Pereira
Journal:  Hormones (Athens)       Date:  2022-10-21       Impact factor: 3.419

2.  Favorable survival and metabolic outcome for children with diencephalic syndrome using a radiation-sparing approach.

Authors:  John-Paul Kilday; Ute Bartels; Annie Huang; Mary Barron; Mary Shago; Matthew Mistry; Nataliya Zhukova; Normand Laperriere; Peter Dirks; Cynthia Hawkins; Eric Bouffet; Uri Tabori
Journal:  J Neurooncol       Date:  2013-11-12       Impact factor: 4.130

Review 3.  Modeling cognitive dysfunction in neurofibromatosis-1.

Authors:  Kelly A Diggs-Andrews; David H Gutmann
Journal:  Trends Neurosci       Date:  2013-01-08       Impact factor: 13.837

4.  Partial empty sella syndrome, GH deficiency and transient central adrenal insufficiency in a patient with NF1.

Authors:  Eleni Magdalini Kyritsi; Maria Hasiotou; Christina Kanaka-Gantenbein
Journal:  Endocrine       Date:  2020-06-09       Impact factor: 3.633

5.  Endocrinological Evaluations of a Neurofibromatosis Type 1 Cohort: Is it Necessary to Evaluate Autoimmune Thyroiditis in Neurofibromatosis Type 1?

Authors:  Serhat Güler; Gözde Yeşil; Hasan Önal
Journal:  Balkan Med J       Date:  2017-05-29       Impact factor: 2.021

Review 6.  Emerging genotype-phenotype relationships in patients with large NF1 deletions.

Authors:  Hildegard Kehrer-Sawatzki; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2017-02-17       Impact factor: 4.132

7.  Neurofibromatosis type 1 of the child increases birth weight.

Authors:  Jussi Leppävirta; Roope A Kallionpää; Elina Uusitalo; Tero Vahlberg; Minna Pöyhönen; Juha Peltonen; Sirkku Peltonen
Journal:  Am J Med Genet A       Date:  2019-04-24       Impact factor: 2.802

8.  Genetic and functional studies implicate synaptic overgrowth and ring gland cAMP/PKA signaling defects in the Drosophila melanogaster neurofibromatosis-1 growth deficiency.

Authors:  James A Walker; Jean Y Gouzi; Jennifer B Long; Sidong Huang; Robert C Maher; Hongjing Xia; Kheyal Khalil; Arjun Ray; David Van Vactor; René Bernards; André Bernards
Journal:  PLoS Genet       Date:  2013-11-21       Impact factor: 5.917

9.  Clinical Presentation and Novel Pathogenic Variants among 68 Chinese Neurofibromatosis 1 Children.

Authors:  Ruen Yao; Tingting Yu; Yufei Xu; Li Yu; Jiwen Wang; Xiumin Wang; Jian Wang; Yiping Shen
Journal:  Genes (Basel)       Date:  2019-10-26       Impact factor: 4.096

10.  Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.

Authors:  Valentina Botero; Bethany A Stanhope; Elizabeth B Brown; Eliza C Grenci; Tamara Boto; Scarlet J Park; Lanikea B King; Keith R Murphy; Kenneth J Colodner; James A Walker; Alex C Keene; William W Ja; Seth M Tomchik
Journal:  Nat Commun       Date:  2021-07-13       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.